US Dollar vs Yen

登録してリアルタイムのチャート、分析ツール、価格を入手してください。

登録

ホーム
投資
株式
アメリカ
NASDAQ
First Wave BioPharma Inc (FWBI)
First Wave BioPharma Inc (FWBI) ニュース

FWBI

First Wave BioPharma (FWBI)

First Wave BioPharma Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:FWBI

1 2 3 4 5 6 7 8 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/05/16	20 : 16	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:FWBI	First Wave BioPharma Inc
2024/05/16	20 : 00	GlobeNewswire Inc.	First Wave BioPharma Changes Name to Entero Therapeutics	NASDAQ:FWBI	First Wave BioPharma Inc
2024/05/15	06 : 26	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:FWBI	First Wave BioPharma Inc
2024/05/14	06 : 26	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:FWBI	First Wave BioPharma Inc
2024/05/14	05 : 59	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NASDAQ:FWBI	First Wave BioPharma Inc
2024/05/10	20 : 55	GlobeNewswire Inc.	First Wave BioPharma, Inc. to raise approximately $1.1 million of Gross Proceeds Priced At-the-Market	NASDAQ:FWBI	First Wave BioPharma Inc
2024/05/09	20 : 00	GlobeNewswire Inc.	First Wave BioPharma and Celiac Journey to Host Nasdaq Event in Support of Celiac Disease Awareness Month	NASDAQ:FWBI	First Wave BioPharma Inc
2024/05/09	06 : 16	Edgar (US Regulatory)	Form 8-K/A - Current report: [Amend]	NASDAQ:FWBI	First Wave BioPharma Inc
2024/04/24	20 : 00	GlobeNewswire Inc.	First Wave BioPharma Announces Invited Paper for Special Edition on Celiac Disease in Peer-Reviewed Scientific Journal, Nutrients	NASDAQ:FWBI	First Wave BioPharma Inc
2024/04/17	20 : 00	GlobeNewswire Inc.	First Wave BioPharma CEO James Sapirstein to Present at the Planet MicroCap Showcase	NASDAQ:FWBI	First Wave BioPharma Inc
2024/04/15	20 : 00	GlobeNewswire Inc.	First Wave BioPharma CEO James Sapirstein to Participate in 2024 Longwood Healthcare Leaders Conference	NASDAQ:FWBI	First Wave BioPharma Inc
2024/03/18	20 : 00	GlobeNewswire Inc.	First Wave BioPharma Announces Two Abstracts on Celiac Disease Research Accepted for Presentation at the 2024 Digestive Disease Week (DDW) Conference	NASDAQ:FWBI	First Wave BioPharma Inc
2024/03/14	19 : 00	GlobeNewswire Inc.	First Wave BioPharma Announces Completion of Business Combination with ImmunogenX, Adding Phase 3-Ready Latiglutenase to its Late-Stage GI-Focused Clinical Pipeline	NASDAQ:FWBI	First Wave BioPharma Inc
2024/03/06	07 : 26	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:FWBI	First Wave BioPharma Inc
2024/03/05	21 : 00	GlobeNewswire Inc.	First Wave BioPharma to Participate In ‘Fireside Chat’ at the 36th Annual Roth Conference	NASDAQ:FWBI	First Wave BioPharma Inc
2024/03/05	07 : 29	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NASDAQ:FWBI	First Wave BioPharma Inc
2024/03/04	22 : 00	GlobeNewswire Inc.	First Wave BioPharma, Inc. to Raise Approximately $4.0 Million of Gross Proceeds in Registered Direct Offering	NASDAQ:FWBI	First Wave BioPharma Inc
2024/02/13	21 : 00	GlobeNewswire Inc.	First Wave BioPharma CEO to Present at the BIO CEO & Investor Conference 2024	NASDAQ:FWBI	First Wave BioPharma Inc
2024/01/23	21 : 00	GlobeNewswire Inc.	First Wave BioPharma to Present at the DealFlow MicroCap Conference	NASDAQ:FWBI	First Wave BioPharma Inc
2024/01/19	06 : 01	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	NASDAQ:FWBI	First Wave BioPharma Inc
2024/01/18	14 : 15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:FWBI	First Wave BioPharma Inc
2024/01/18	06 : 02	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:FWBI	First Wave BioPharma Inc
2024/01/17	21 : 00	GlobeNewswire Inc.	First Wave BioPharma CEO to Present at the Sequire Investor Summit 2024 in Puerto Rico	NASDAQ:FWBI	First Wave BioPharma Inc
2024/01/09	07 : 14	Edgar (US Regulatory)	Form S-3 - Registration statement under Securities Act of 1933	NASDAQ:FWBI	First Wave BioPharma Inc
2024/01/05	07 : 13	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:FWBI	First Wave BioPharma Inc
2024/01/05	07 : 13	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:FWBI	First Wave BioPharma Inc
2024/01/04	22 : 22	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:FWBI	First Wave BioPharma Inc
2024/01/04	20 : 00	GlobeNewswire Inc.	First Wave BioPharma Chairman and CEO Issues Letter to Shareholders Highlighting Recent Accomplishments and Outlook for 2024	NASDAQ:FWBI	First Wave BioPharma Inc
2024/01/04	09 : 54	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:FWBI	First Wave BioPharma Inc
2023/12/29	02 : 21	Edgar (US Regulatory)	Form RW - Registration Withdrawal Request	NASDAQ:FWBI	First Wave BioPharma Inc

Showing the most relevant articles for your search:NASDAQ:FWBI

1 2 3 4 5 6 7 8 次へ >>

Citigroup Global Markets...

BNP Paribas Issuance

BNP Paribas Issuance

Vontobel Financial Produ...

Vontobel Financial Produ...

Direxion Daily 20 Year T...

Critical Resources

Pond Technologies

Franklin Bitcoin ETF

BNP Paribas Issuance

BNP Paribas Issuance

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約